Diabetes News Archive

Novo Nordisk, Amylin Pharmaceuticals shares rise on FDA approval of diabetes drug Victoza Novo Nordisk - Amylin Pharmaceuticals - Victoza - Diabetes - Health

TUESDAY, Jan. 26 (HealthDay News) -- Victoza (liraglutide) has been approved to treat type 2 diabetes in some adults, the U.S. Food and Drug Administration said in a news release.

Shares of several drug developers focusing on diabetes drugs advanced Tuesday following the Food and Drug Administration's approval of Novo Nordisk's once-daily drug Victoza. The regulatory decision could open up a clearer path for other drugs within the GLP-... Novo Nordisk - Food and Drug Administration - Liraglutide - Victoza - Diabetes mellitus

Title: Half With Diabetes Skip Insulin Injections Category: Health News Created: 1/26/2010 9:35:00 AM Last Editorial Review: 1/26/2010 9:35:56 AM

Shares of several drug developers focusing on diabetes drugs advanced Tuesday following the Food and Drug Administration's approval of Novo Nordisk's once-daily drug Victoza.

More than half of the people prescribed insulin injections to control their diabetes have skipped their injections in the past, and one in five do so sometimes or often, according to a new study.

NEW YORK -(Dow Jones)- The Food and Drug Administration's approval of Novo Nordisk's new diabetes drug provides competition to Byetta, sold by Amylin Pharmaceuticals Inc. (AMLN) and Eli Lilly & Co. (LLY), but it also may give insights in the approval of a longer-acting version of Byetta under review by the agency.

Drug stocks slip in early action, though shares of Novo Nordisk A/S, Amylin Pharmaceuticals and Alkermes rally on news that the FDA has approved Novo Nordisk's new diabetes medication.

Drug stocks edge higher, as shares of Novo Nordisk, Amylin Pharmaceuticals Inc. and Alkermes Inc. gain on news that the FDA has approved Novo Nordisk's new diabetes medication.

The first ever diabetes audit of 200 NHS hospitals has found that 20 per cent of patients on hospital wards have diabetes - twice the proportion previously estimated. In addition, the audit, which is due to be published later this year, will also show that people with diabetes stay in hospital longer than other patients...

We are looking for more media volunteers to help us raise awareness of diabetes. A media volunteer is someone who is willing to be interviewed by a journalist. When there is a diabetes news story in the papers or on TV or radio, the story often includes an interview with a person with diabetes. The media likes to have a 'human face' to the story, somebody who the audience can relate to...

The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults. Victoza is intended to help lower blood sugar levels along with diet, exercise, and selected other diabetes medicines. It is not recommended as initial therapy in patients who have not achieved adequate diabetes control on diet and exercise alone. Insulin is ...

Novo Nordisk announced that the US Food and Drug Administration (FDA) has granted marketing authorisation for Victoza(R) for the treatment of type 2 diabetes in adults. Victoza(R) is the brand name approved in the US and Europe for liraglutide, the first once-daily human Glucagon-Like Peptide-1 (GLP-1) analogue developed for the treatment of type 2 diabetes. In the US, Victoza(R) is indicated as an ...

WASHINGTON, Jan. 26 (UPI) -- The U.S. Food and Drug Administration says it has approved Victoza, a once-daily injection to treat type 2 diabetes in some adults.

New research that significantly improves our understanding of how insulin interacts with cells in the human body is published today. The study could have major implications for the development of treatments for Type I diabetes. By developing and analysing a range of super active insulins, scientists from the York Structural Biology Laboratory at the University of York have been able to identify ...

FDA's decision is seen as boosting approval odds for another diabetes drug from Amylin Pharma and Eli Lilly.

Novo Nordisk's market capitalization swells by around $2.5 billion on Tuesday after U.S. authorities approved a diabetes drug from the Danish firm.

The U.S. Food and Drug Administration approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.

Jan. 26 (Bloomberg) -- Ipsen SA , the French drugmaker that developed an experimental diabetes medicine, rose the most in eight weeks in Paris trading after Novo Nordisk A/S won U.S. regulatory approval for a competing product.

LONDON -- Drugmaker Novo Nordisk said Tuesday that it has received U.S. approval for its Victoza medicine to treat type 2 diabetes. The firm said that it has been granted marketing authorisation for ...

Health Calendar: Lymphoma, women's health, diabetes

Novo Nordisk Gets FDA Approval For Diabetes Drug

Washington, Jan 26 : Better treatments for Type I diabetes may be on the anvil, thanks to a new study which improves the understanding of how insulin interacts with cells in the human body.

WASHINGTON: U.S. health officials on Monday approved Danish drugmaker Novo Nordisk's once-daily injection for treating type 2 diabetes but said more safety studies are needed before it can be cleared ...

WASHINGTON: U.S. health officials on Monday approved Danish drugmaker Novo Nordisk's once-daily injection for treating type 2 diabetes but said more safety studies are needed before it can be cleared as a first-line treatment for the disease.

FDA approves Victoza, once-daily injection for type 2 diabetes made by Denmark's Novo-Nordisk Novo Nordisk - Diabetes mellitus type 2 - Health - Conditions and Diseases - Endocrine Disorders

Federal health officials on Monday approved Danish drugmaker Novo Nordisk's once-daily injection for treating type 2 diabetes but said more safety studies are needed before it can be cleared as a first-line treatment for the disease. The Food and Drug... Novo Nordisk - Health - Diabetes mellitus type 2 - Conditions and Diseases - Endocrine Disorders

Federal health officials on Monday approved Danish drugmaker Novo Nordisk's once-daily injection for treating type 2 diabetes but said more safety studies are needed before it can be cleared as a first-line treatment for the...

The Rapid City Indian Health Service and the Flandreau Santee Sioux Tribe will receive $945,976 in funding as part of the Special Diabetes Program for Indians, which will support diabetes treatment and prevention activities for Native American communities.

Federal health officials on Monday approved Danish drugmaker Novo Nordisk's once-daily injection for treating type 2 diabetes but said more safety studies are needed before it can be cleared as a first-line treatment for the disease.

BAGSVæRD, DENMARK--(Marketwire - 01/25/10) - Novo Nordisk announced today that the US Food and Drug Administration (FDA) has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults. Victoza is the brand name approved in the US and Europe for liraglutide, the first once-daily human Glucagon-Like Peptide-1 (GLP-1) analogue developed for the treatment of type 2 ...

Novo Nordisk A/S, the world's largest maker of insulin, won U.S. Food and Drug Administration approval for its diabetes drug Victoza after safety concerns delayed the agency's decision by about 10 months.

Jan. 25 (Bloomberg) -- Novo Nordisk A/S , the world's largest maker of insulin, won U.S. Food and Drug Administration approval for its diabetes drug Victoza after safety concerns delayed the agency's decision by about 10 months.

The Food and Drug Administration approved type 2 diabetes treatment Victoza, made by Novo Nordisk A/S (NVO, NOVO-B.KO), but ordered the Danish pharmaceutical company to conduct further studies on its safety.

DFM to host Diabetes Conference

The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.